Campbell Newman Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-6,547
| Closed | -$554K | – | 125 |
|
|
2018
Q4 | $554K | Buy |
6,547
+2,525
| +63% | +$214K | 0.1% | 90 |
|
|
2018
Q3 | $689K | Sell |
4,022
-2,095
| -34% | -$359K | 0.1% | 87 |
|
|
2018
Q2 | $791K | Buy |
6,117
+263
| +4% | +$34K | 0.12% | 71 |
|
|
2018
Q1 | $603K | Buy |
5,854
+252
| +4% | +$26K | 0.1% | 88 |
|
|
2017
Q4 | $479K | Buy |
5,602
+1,021
| +22% | +$87.3K | 0.08% | 96 |
|
|
2017
Q3 | $389K | Buy |
4,581
+583
| +15% | +$49.5K | 0.07% | 94 |
|
|
2017
Q2 | $303K | Buy |
3,998
+183
| +5% | +$13.9K | 0.05% | 102 |
|
|
2017
Q1 | $252K | Buy |
3,815
+457
| +14% | +$30.2K | 0.05% | 105 |
|
|
2016
Q4 | $213K | Buy |
+3,358
| New | +$213K | 0.04% | 109 |
|